6th In-House Impact: Biopharma Summit 2025

As the regulatory landscape continues to evolve, 2025 is a pivotal year for legal leaders in biopharma. The 6th In-House Impact: Biopharma Summit is your exclusive opportunity to unite with top legal minds from Takeda, Kura Oncology, Neurocrine Biosciences, and more to tackle today’s most pressing challenges—tariffs, financing, M&A strategy, and beyond. Tailored for General Counsels and Chief Legal Officers at drug development companies, this intimate, peer-led summit empowers you to elevate legal as a business-critical function. Learn how in-house teams are adapting to economic volatility, harnessing new legal tech, and navigating cross-functional leadership demands, all while building a valuable network of peers. This is not just another conference. It’s a strategic inflection point. Free to attend for biopharma’s in-house counsel, this event will help you transition from a traditional lawyer to a corporate leader, ready to drive business success.

Event Links

Website: https://go.evvnt.com/3049692-0

Tickets: https://go.evvnt.com/3049692-1

Brochure: https://go.evvnt.com/3049692-2

Read More

View Less